A 3D human neural cell culture system for modeling Alzheimer's disease

Nature Protocols

Volumn 10, Issue 7, 2015, Pages 985-1006

  Kim, Young Hye ^a,b   Choi, Se Hoon ^a   D'Avanzo, Carla ^a   Hebisch, Matthias ^a,c   Sliwinski, Christopher ^a   Bylykbashi, Enjana ^a   Washicosky, Kevin J ^a   Klee, Justin B ^a   Brüstle, Oliver ^c   Tanzi, Rudolph E ^a   Kim, Doo Yeon ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN; AMYLOID BETA PROTEIN; MAPT PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL POPULATION; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNAL RIBOSOME ENTRY SITE; NERVE CELL CULTURE; NEURAL STEM CELL; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; CELL LINE; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PROCEDURES; PROTEINOSIS;

ANIMALIA;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; HUMANS; MODELS, NEUROLOGICAL; MUTATION; NEURAL STEM CELLS; PROTEIN AGGREGATION, PATHOLOGICAL; TAU PROTEINS;

EID: 84933037007     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2015.065     Document Type: Article

References (44)

1. Tanzi, R.E. & Bertram, L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555 (2005).
2. Götz, J. & Ittner, L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 9, 532-544 (2008).
3. Chin, J. Selecting a mouse model of Alzheimer's disease. Methods Mol. Biol. 670, 169-189 (2011).
4. Oddo, S. et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421 (2003).
5. Yagi, T. et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum. Mol. Genet. 20, 4530-4539 (2011).
6. Israel, M.A. et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 482, 216-220 (2012).
7. Shi, Y. et al. A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci. Transl. Med. 4, 124ra29 (2012).
8. Kondo, T. et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell 12, 487-496 (2013).
9. Sproul, A.A. et al. Characterization and molecular profling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors. PLoS ONE 9, e84547 (2014).
10. Muratore, C.R. et al. The familial Alzheimer's disease APPV717I mutation alters APP processing and tau expression in iPSC-derived neurons. Hum. Mol. Genet. 23, 3523-3536 (2014).
11. Choi, S.H. & Tanzi, R.E. iPSCs to the rescue in Alzheimer's research. Cell Stem Cell 10, 235-236 (2012).
12. Saha, K. & Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584-595 (2009).
13. Young, J.E. & Goldstein, L.S.B. Alzheimer's disease in a dish: promises and challenges of human stem cell models. Hum. Mol. Genet. 21, R82-R89 (2012).
14. Choi, S.H. et al. A three-dimensional human neural cell culture model of Alzheimer's disease. Nature 515, 274-278 (2014).
15. Donato, R. et al. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 8, 36 (2007).
16. Hoffrogge, R. et al. 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 6, 1833-1847 (2006).
17. Beyer, S. et al. Neuroproteomics in stem cell differentiation. Proteomics Clin. Appl. 1, 1513-1523 (2007).
18. Le, M.T.N. et al. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell Biol. 29, 5290-5305 (2009).
19. Morgan, P.J. et al. Protection of neurons derived from human neural progenitor cells by veratridine. Neuroreport 20, 1225-1229 (2009).
20. Lange, C. et al. Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells. Neurosci. Lett. 488, 36-40 (2011).
21. Hernández-Benítez, R., Vangipuram, S.D., Ramos-Mandujano, G., Lyman, W.D. & Pasantes-Morales, H. Taurine enhances the growth of neural precursors derived from fetal human brain and promotes neuronal specifcation. Dev. Neurosci. 35, 40-49 (2013).
22. Mazemondet, O. et al. Quantitative and kinetic profle of Wnt/β-catenin signaling components during human neural progenitor cell differentiation. Cell. Mol. Biol. Lett. 16, 515-538 (2011).
23. Liedmann, A., Rolfs, A. & Frech, M.J. Cultivation of human neural progenitor cells in a 3-dimensional self-assembling peptide hydrogel. J. Vis. Exp 59, e3830 (2012).
24. Hovakimyan, M. et al. Survival of transplanted human neural stem cell line (ReNcell VM) into the rat brain with and without immunosuppression. Ann. Anat. 194, 429-435 (2012).
25. Hübner, R. et al. Differentiation of human neural progenitor cells regulated by Wnt-3a. Biochem. Biophys. Res. Commun. 400, 358-362 (2010).
26. Jaeger, A., Baake, J., Weiss, D.G. & Kriehuber, R. Glycogen synthase kinase-3β regulates differentiation-induced apoptosis of human neural progenitor cells. Int. J. Dev. Neurosci. 31, 61-68 (2013).
27. Chaudhry, Z.L. & Ahmed, B.Y. Caspase-2 and caspase-8 trigger caspase-3 activation following 6-OHDA-induced stress in human dopaminergic neurons differentiated from ReNVM stem cells. Neurol. Res. 35, 435-440 (2013).
28. Hughes, C.S., Postovit, L.M. & Lajoie, G.A. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10, 1886-1890 (2010).
29. Ortinau, S. et al. Effect of 3D-scaffold formation on differentiation and survival in human neural progenitor cells. Biomed. Eng. Online 9, 70 (2010).
30. LaPlaca, M.C., Vernekar, V.N., Shoemaker, J.T. & Cullen, D.K. Three-dimensional neuronal cultures. in Methods in Bioengineering: 3D Tissue Engineering (eds. Berthiaume, F. & Morgan, J.) 187-204 (Artech House 2010).
31. Suga, H. et al. Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480, 57-62 (2011).
32. Li, H., Wijekoon, A. & Leipzig, N.D. 3D differentiation of neural stem cells in macroporous photopolymerizable hydrogel scaffolds. PLoS ONE 7, e48824 (2012).
33. Liedmann, A., Frech, S., Morgan, P.J., Rolfs, A. & Frech, M.J. Differentiation of human neural progenitor cells in functionalized hydrogel matrices. Biores. Open Access 1, 16-24 (2012).
34. Tang-Schomer, M.D. et al. Bioengineered functional brain-like cortical tissue. Proc. Natl. Acad. Sci. USA 111, 13811-13816 (2014).
35. Falk, A. et al. Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS ONE 7, e29597 (2012).
36. Zhang, D. et al. A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials 35, 1420-1428 (2014).
37. Cathomen, T. & Joung, J.K. Zinc-fnger nucleases: the next generation emerges. Mol. Ther. 16, 1200-1207 (2008).
38. Mussolino, C. & Cathomen, T. TALE nucleases: tailored genome engineering made easy. Curr. Opin. Biotechnol. 23, 644-650 (2012).
39. Hsu, P.D., Lander, E.S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278 (2014).
40. Iovino, M., Patani, R., Watts, C., Chandran, S. & Spillantini, M.G. Human stem cell-derived neurons: a system to study human tau function and dysfunction. PLoS ONE 5, e13947 (2010).
41. Ingelsson, M. et al. No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathol. 112, 439-449 (2006).
42. Sena-Esteves, M., Tebbets, J.C., Steffens, S., Crombleholme, T. & Flake, A.W. Optimized large-scale production of high titer lentivirus vector pseudotypes. J. Virol. Methods 122, 131-139 (2004).
43. Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-?C(T)) method. Methods 25, 402-408 (2001).
44. Schmued, L. et al. Introducing Amylo-Glo, a novel fuorescent amyloid specifc histochemical tracer especially suited for multiple labeling and large scale quantifcation studies. J. Neurosci. Methods 209, 120-126 (2012).